Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrapeptide repeat homeobox-like (TPRXL) is a human gene considered a member of the homeobox gene family, encoding a putative DNA-binding protein with a homeodomain[1][3][5]. The gene is denoted as a **pseudogene**, meaning it is widely *thought not to code for a functional protein* in humans[3][6]. It has been characterized alongside functional homeobox genes, which typically play roles in transcriptional regulation during early development, including zygotic genome activation[3][8]. However, unlike its paralog TPRX1, there is *no conclusive evidence* that the TPRXL locus encodes an active protein or is a therapeutic target. At least one report identified TPRXL as a potential biomarker in myelodysplastic syndrome, but this has not been broadly validated[7]. **Key notes:** - TPRXL is a **pseudogene**; its product is likely non-functional in most if not all humans[3][6]. - Not considered a therapeutic target such as receptor, enzyme, or transporter[3][6]. - Lists as a putative transcription factor are due to sequence homology, not demonstrated activity[3][1]. - No known interacting drugs, mechanisms of action, or associated safety concerns. - Some aliases or alternative identifiers may refer to earlier classifications or predictions, but current annotations consistently list as a pseudogene[3][6]. - Its close paralog, TPRX1 (Tetrapeptide repeat homeobox 1), *is* a protein-coding gene with established transcription factor functions[2]. If you are looking for a functional homeobox transcription factor, TPRX1 may be the intended target rather than TPRXL.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrapeptide repeat homeobox-like (TPRXL).